home All News open_in_new Full Article

Novo Nordisk enttäuscht Anleger mit Studiendaten zu Abnehmspritzen

Pharma - Novo Nordisk enttäuscht die Investoren mit neuen Studiendaten zu der nächsten Generation seiner Abnehmspritze.


today 3 w. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Technology
attach_file Other
attach_file Other
attach_file Technology
attach_file Technology
attach_file Technology
attach_file Other
attach_file Politics
attach_file Politics
attach_file Other
attach_file Other


ID: 172383818
Add Watch Country

arrow_drop_down